A number of guidance documents have been published in recent years that have encouraged industry and NHS to join forces. Closer working with industry will ultimately lead to better outcomes for our patients.

The Christie has nine partnerships, six with pharmaceutical companies and three with clinical research organisations (CROs).

What are the benefits to having commercial partnerships?

  • Improve health outcomes for our patients through collaboration and understanding of the future advances in medicines
  • Insight into industry pipeline of studies.
  • Received funding for clinical fellows, PhD students and research nurses to support industry-led trials
  • Increased volume of clinical trials and revenue
  • Market insight – competitor analysis and feedback
  • Steady stream of research opportunities helps develop investigators career path and attract high calibre staff.

What is the role of the Research Partnership Facilitator?

The research partnership facilitator provides a single point of contact for our commercial partners.

  • This ensures the company and the site are working together to understand each other’s processes and ways of working.
  • It provides a close link between R&D staff and disease teams
  • It helps us see problems early

How do we work with our partners?

We hold strategic meetings between senior R&D personnel and commercial organisations. We hold disease-specific meetings as required, operational meetings to cover the set-up and progress of work, and we hold showcase events as required.


Working closely with our partners we have delivered the following achievements:

  • The first site to open globally and in the UK
  • First site to recruit a patient globally and in the UK
  • Highest recruitment to studies

Manchester University Manchester Academic Health Science CentreCancer Research UK National Institute for Health Records